156 related articles for article (PubMed ID: 14530810)
1. Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of patients with myeloproliferative disorders (MPD).
Wróbel T; Mazur G; Surowiak P; Wolowiec D; Jelen M; Kuliczkowsky K
Pathol Oncol Res; 2003; 9(3):170-3. PubMed ID: 14530810
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of vascular endothelial growth factor in bone marrow of multiple myeloma patients.
Wróbel T; Mazur G; Surowiak P; Dzie Giel P; Usnarska-Zubkiewicz L; Kuliczkowski K
Eur J Intern Med; 2003 Mar; 14(2):98-100. PubMed ID: 12719026
[TBL] [Abstract][Full Text] [Related]
3. Absence of clinical prognostic value of vascular endothelial growth factor and microvessel density in multiple myeloma.
Choi JH; Ahn MJ; Jang SJ; Park CK; Park YW; Oh HS; Lee YY; Choi IY; Kim IS
Int J Hematol; 2002 Dec; 76(5):460-4. PubMed ID: 12512841
[TBL] [Abstract][Full Text] [Related]
4. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
Marković O; Marisavljević D; Cemerikić V; Vidović A; Perunicić M; Todorović M; Elezović I; Colović M
Med Oncol; 2008; 25(4):451-7. PubMed ID: 18449811
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of angiogenesis and matrix metalloproteinase-2 secretion in bone marrow of multiple myeloma patients before and after the treatment.
Bolkun L; Lemancewicz D; Sobolewski K; Mantur M; Semeniuk J; Kulczynska A; Kloczko J; Dzieciol J
Adv Med Sci; 2013; 58(1):118-25. PubMed ID: 23333895
[TBL] [Abstract][Full Text] [Related]
6. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
Zou WR; Liu T; Meng WT; Yu J; Niu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow immunohistochemical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia.
Chou JM; Li CY; Tefferi A
Leuk Res; 2003 Jun; 27(6):499-504. PubMed ID: 12648509
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis and survival in patients with myelodysplastic syndrome.
Savic A; Cemerikic-Martinovic V; Dovat S; Rajic N; Urosevic I; Sekulic B; Kvrgic V; Popovic S
Pathol Oncol Res; 2012 Jul; 18(3):681-90. PubMed ID: 22270865
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases.
Giles FJ; Cooper MA; Silverman L; Karp JE; Lancet JE; Zangari M; Shami PJ; Khan KD; Hannah AL; Cherrington JM; Thomas DA; Garcia-Manero G; Albitar M; Kantarjian HM; Stopeck AT
Cancer; 2003 Apr; 97(8):1920-8. PubMed ID: 12673719
[TBL] [Abstract][Full Text] [Related]
10. CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia.
Fu J; Fu J; Chen X; Zhang Y; Gu H; Bai Y
Jpn J Clin Oncol; 2010 Nov; 40(11):1046-52. PubMed ID: 20558462
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status.
Medinger M; Skoda R; Gratwohl A; Theocharides A; Buser A; Heim D; Dirnhofer S; Tichelli A; Tzankov A
Br J Haematol; 2009 Jul; 146(2):150-7. PubMed ID: 19466975
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid.
Kini AR; Peterson LA; Tallman MS; Lingen MW
Blood; 2001 Jun; 97(12):3919-24. PubMed ID: 11389035
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
[TBL] [Abstract][Full Text] [Related]
14. [Coexpression of VEGF and bFGF is associated with increased vascular density in head and neck carcinomas].
Riedel F; Götte K; Schwalb J; Bergler W; Hörmann K
Laryngorhinootologie; 2000 Dec; 79(12):730-5. PubMed ID: 11199455
[TBL] [Abstract][Full Text] [Related]
15. The expression of osteopontin and vascular endothelial growth factor in correlation with angiogenesis in monoclonal gammopathy of undetermined significance and multiple myeloma.
Babarović E; Valković T; Budisavljević I; Balen I; Štifter S; Duletić-Načinović A; Lučin K; Jonjić N
Pathol Res Pract; 2016 Jun; 212(6):509-16. PubMed ID: 26997492
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of bone marrow angiogenesis in idiopathic myelofibrosis.
Ni H; Barosi G; Hoffman R
Am J Clin Pathol; 2006 Aug; 126(2):241-7. PubMed ID: 16891200
[TBL] [Abstract][Full Text] [Related]
17. Serum levels, and bone marrow immunohistochemical expression of, vascular endothelial growth factor in patients with chronic myeloproliferative diseases.
Panteli K; Bai M; Hatzimichael E; Zagorianakou N; Agnantis NJ; Bourantas K
Hematology; 2007 Dec; 12(6):481-6. PubMed ID: 17852434
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity.
Lundberg LG; Lerner R; Sundelin P; Rogers R; Folkman J; Palmblad J
Am J Pathol; 2000 Jul; 157(1):15-9. PubMed ID: 10880370
[TBL] [Abstract][Full Text] [Related]
19. VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms.
Subotički T; Mitrović Ajtić O; Živković E; Diklić M; Đikić D; Tošić M; Beleslin-Čokić B; Dragojević T; Gotić M; Santibanez JF; Čokić V
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206393
[TBL] [Abstract][Full Text] [Related]
20. [Angiogenesis in different clinical phases of chronic myeloid leukemia].
Krasowska-Kwiecień A; Kijowski J; Łukasiewicz E; Sacha T; Foryciarz K; Majka M; Ratajczak MZ; Skotnicki AB
Przegl Lek; 2009; 66(9):471-8. PubMed ID: 21033405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
